UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis

Current HIV research, 2016-01, Vol.14 (4), p.346

2016

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 ＂Trans-Signaling＂ and Ischemic Vascular Disease: The Important Role of Soluble gp130

Mediators of Inflammation, 2017-01, Vol.2017, p.1396398-6

2017

Link zum Volltext

Verfügbarkeit prüfen

Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes

Cardiovascular diabetology, 2021-07, Vol.20 (1), p.144-144, Article 144

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care

Cardiovascular diabetology, 2022-12, Vol.21 (1), p.274-12, Article 274

2022

Link zum Volltext

Verfügbarkeit prüfen

In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study

Scientific reports, 2022-03, Vol.12 (1), p.3474-3474, Article 3474

2022

Link zum Volltext

Verfügbarkeit prüfen

Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer’s Disease

Gerontology (Basel), 2018-08, Vol.64 (5), p.414-421

2018

Link zum Volltext

Verfügbarkeit prüfen

Combining LDL-C and HDL-C to predict survival in late life: The InChianti study

PloS one, 2017-09, Vol.12 (9), p.e0185307-e0185307

2017

Link zum Volltext

Verfügbarkeit prüfen

Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims

Scientific reports, 2022-05, Vol.12 (1), p.7762-7762, Article 7762

2022

Link zum Volltext

Verfügbarkeit prüfen

Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

Cardiovascular diabetology, 2022-04, Vol.21 (1), p.57-57, Article 57

2022

Link zum Volltext

Verfügbarkeit prüfen

Age-related differences in plasma BDNF levels after prolonged bed rest

Journal of applied physiology (1985), 2016-05, Vol.120 (10), p.1118-1123

2016

Link zum Volltext

Verfügbarkeit prüfen

Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study

Cardiovascular diabetology, 2019-09, Vol.18 (1), p.117-117, Article 117

2019

Link zum Volltext

Verfügbarkeit prüfen

Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study

Atherosclerosis, 2013-01, Vol.226 (1), p.201-207

2013

Link zum Volltext

Verfügbarkeit prüfen

Deciphering dementia in the cardiometabolic continuum

European heart journal, 2023-02, Vol.44 (7), p.583-585

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial on “Genetics And Metabolic Diseases” Special Issue

Advanced biology, 2023-12, Vol.7 (12), p.e2300464-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

Diabetes research and clinical practice, 2020-10, Vol.168, p.108374-108374, Article 108374

2020

Link zum Volltext

Verfügbarkeit prüfen

First case of 2 intraductal papillary mucinous tumors of both ventral and dorsal ducts in pancreas divisum

Pancreas, 2010-01, Vol.39 (1), p.110-111

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of dapagliflozin vs DPP‐4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world

Diabetes/metabolism research and reviews, 2021-01, Vol.37 (1), p.e3353-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control study

Diabetes, obesity & metabolism, 2020-10, Vol.22 (10), p.1946-1950

2020

Link zum Volltext

Verfügbarkeit prüfen

Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes

Journal of the American College of Cardiology, 2020-06, Vol.75 (23), p.2995-2996

2020

Link zum Volltext

Verfügbarkeit prüfen

Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial

Diabetologia, 2021-10, Vol.64 (10), p.2334-2344

2021

Link zum Volltext

Verfügbarkeit prüfen

Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history

The lancet. Diabetes & endocrinology, 2022-12, Vol.10 (12), p.882-889

2022

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients

The journal of clinical endocrinology and metabolism, 2020-07, Vol.105 (7), p.e2617-e2625

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies

Metabolism, clinical and experimental, 2020-05, Vol.106, p.154190, Article 154190

2020

Link zum Volltext

Verfügbarkeit prüfen

Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies

Diabetes care, 2022-08, Vol.45 (8), p.1882-1892

2022

Link zum Volltext

Verfügbarkeit prüfen

Fixed versus flexible combination of GLP‐1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study

Diabetes, obesity & metabolism, 2019-11, Vol.21 (11), p.2542-2552

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(40)
Science & Technology
(36)
Life Sciences & Biomedicine
(33)
Male
(24)
Female
(23)
Endocrinology & Metabolism
(21)
Aged
(20)
Middle Aged
(16)
Diabetes
(15)
Diabetes Mellitus
(14)
Diabetes Mellitus, Type 2 - Drug Therapy
(13)
Risk Factors
(13)
Cardiac & Cardiovascular Systems
(11)
Cardiovascular Diseases
(11)
Cardiovascular System & Cardiology
(11)
Retrospective Studies
(11)
Diabetes Mellitus, Type 2 - Complications
(9)
Mortality
(9)
Adult
(8)
Cardiovascular Disease
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis

Interleukin-6 ＂Trans-Signaling＂ and Ischemic Vascular Disease: The Important Role of Soluble gp130

Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes

Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care

In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study

Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer’s Disease

Combining LDL-C and HDL-C to predict survival in late life: The InChianti study

Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims

Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

Age-related differences in plasma BDNF levels after prolonged bed rest

Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study

Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study

Deciphering dementia in the cardiometabolic continuum

Editorial on “Genetics And Metabolic Diseases” Special Issue

Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

First case of 2 intraductal papillary mucinous tumors of both ventral and dorsal ducts in pancreas divisum

Comparative effectiveness of dapagliflozin vs DPP‐4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world

Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control study

Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes

Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial

Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history

Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients

Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies

Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies

Fixed versus flexible combination of GLP‐1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study

Aktive Filter

Suchergebnisse filtern